Progressive multifocal leukoencephalopathy

Neurobiology of Disease

Volumn , Issue , 2007, Pages 185-195

  Brooks, Benjamin ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884037345     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088592-3/50019-0     Document Type: Chapter

References (56)

1. Polyomaviruses and human diseases. Advances in Experimental Medicine and Biology 2006, 1-387. Springer, New York. N. Ahsan, N. Ahsan (Eds.).
2. Astrom K., Mancall E., Richardson E.P. Progressive multi-focal leukoencephalopathy: a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin' s disease. Brain 1958, 81:93-111.
3. Human Polyomaviruses: Molecular and Clinical Perspectives 2001, John Wiley & Sons, New York. K. Khalili, G.L. Stoner (Eds.).
4. Clinical Neurovirology 2003, Marcel Dekker, New York. A. Nath, J.R. Berger (Eds.).
5. Beck R.C., Kohn D.J., Tuohy M.J., Prayson R.A., Yen-Lieberman B., Procop G.W. Detection of polyoma virus in brain tissue of patients with progressive multifocal leukoencephalopathy by real-time PCR and pyrosequencing. Diagn. Mol. Pathol. 2004, 13:15-21.
6. Berger J.R. JCV-specific CD4 T cell response: another piece of the puzzle in explaining some aspects of AIDS associated PML. AIDS 2003, 17:1557-1559.
7. Berger J.R. Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness. J. Neurovirol. 2003, 9(suppl. 1):38-41.
8. Berger J.R., Levy R.M., Flomenhoft D., Dobbs M. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann. Neurol. 1998, 44:341-349.
9. Berger J.R., Pall L., Lanska D., Whiteman M. Progres-sive multifocal leukoencephalopathy in patients with HIV infection. J. Neurovirol. 1998, 4:59-68.
10. Bofill-Mas S., Clemente-Casares P., Major E.O., Curfman B., Girones R. Analysis of the excreted JC virus strains and their potential oral transmission. J. Neurovirol. 2003, 9:498-507.
11. Bofill-Mas S., Girones R. Role of the environment in the transmission of JC virus. J. Neurovirol. 2003, 9(suppl. 1):54-58.
12. Brooks B.R., Walker D.L. Progressive multifocal leukoen-cephalopathy. Neurol. Clin. 1984, 2:299-313.
13. Darbinyan A., Siddiqui K.M., Slonina D., Darbinian N., Amini S., White M.K., Khalili K. Role of JC virus agnoprotein in DNA repair. J. Virol. 2004, 78:8593-8600.
14. Davies N.W., Brown L.J., Gonde J., Irish D., Robinson R.O., Swan A.V., Banatvala J., Howard R.S., Sharief M.K., Muir P. Factors influencing PCR detection of viruses in cerebrospinal fluid of patients with suspected CNS infections. J. Neurol. Neurosurg. Psychiatry 2005, 76:82-87.
15. Delbue S., Sotgiu G., Fumagalli D., Valli M., Borghi E., Mancuso R., Marchioni E., Maserati R., Ferrante P. A case of a progressive multifocal leukoencephalopathy patient with four different JC virus transcriptional control region rearrangements in cerebrospinal flu. J. Neurovirol. 2005, 11:51-57.
16. Du Pasquier R.A., Kuroda M.J., Zheng Y., Jean-Jacques J., Letvin N.L., Koralnik I.J. A prospective study demon-strates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoenceph. Brain 2004, 127:1970-1978.
17. Enam S., Sweet T.M., Amini S., Khalili K., Del Valle L. Evidence for involvement of transforming growth factor beta1 signaling pathway in activation of JC virus in human immunodeficiency virus 1-associated progress. Arch. Pathol. Lab. Med. 2004, 128:282-291.
18. Fedele C.G., Ciardi M.R., Delia S., Contreras G., Perez J.L., De Ona M., Vidal E., Tenorio A. Identical rearranged forms of JC polyomavirus transcriptional control region in plasma and cerebrospinal fluid of acquired immunodeficiency syndrome patients. J. Neurovirol. 2003, 9:551-558.
19. Gallia G.L., Houff S.A., Major E.O., Khalili K. Review: JC virus infection of lymphocytes-revisited. J. Infect. Dis. 1997, 176:1603-1609.
20. Gasnault J., Kahraman M., de Goer de Herve M.G., Durali D., Delfraissy J.F., Taoufik Y. Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoen-cephalopathy. AIDS 2003, 17:1443-1449.
21. Goldmann C., Petry H., Frye S., Ast O., Ebitsch S., Jentsch K.D., Kaup F.J., Weber F., Trebst C., Nisslein T., Hunsmann G., Weber T., Luke W. Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: formation of virus-like particles useful for immunologica. J. Virol. 1999, 73:4465-4469.
22. Holman R.C., Janssen R.S., Buehler J.W., Zelasky M.T., Hooper W.C. Epidemiology of progressive multifocal leukoen-cephalopathy in the United States: analysis of national mortality and AIDS surveillance data. Neurology 1991, 41:1845-1846.
23. Holman R.C., Torok T.J., Belay E.D., Janssen R.S., Schonberger L.B. Progressive multifocal leukoencephalopathy in the United States, 1979-1994: increased mortality associated with HIV infection. Neuroepidemiology 1998, 17:303-309.
24. Holmes E.C. The phylogeography of human viruses. Mol. Ecol. 2004, 13:745-756.
25. Isella V., Marzorati V., Curtò N., Cappellini A., Appollonioa I. Primary progressive multifocal leukoencephalopathy: report of a case. Funct. Neurol. 2005, 20:139-142.
26. Katz-Brull R., Lenkinski R.E., Du Pasquier R.A., Koralnik I.J. Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy. Neurology 2004, 63:897-900.
27. Kim J., Woolridge S., Biffi R., Borghi E., Lassak A., Ferrante P., Amini S., Khalili K., Safak M. Members of the AP-1 family, c-Jun and c-Fos, functionally interact with JC virus early regu-latory protein large T antigen. J. Virol. 2003, 77:5241-5252.
28. Kleinschmidt-DeMasters B.K., Tyler K.L. Progressive multi-focal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N. Engl. J. Med. 2005, 353:369-374.
29. Knowles W.A., Sasnauskas K. Comparison of cell culture-grown JC virus [primary human fetal glial cells and the JCI cell line] and recombinant JCV VP1 as antigen for the detection of anti. J. Virol. Methods 2003, 109:47-54.
30. Komagome R., Sawa H., Suzuki T., Suzuki Y., Tanaka S., Atwood W.J., Nagashima K. Oligosaccharides as receptors for JC virus. Journal of Virology 2002, 76:12992-13000.
31. Koralnik I.J., Schellingerhout D., Frosch M.P. Case records of the Massachusetts General Hospital. Weekly clinicopathological exer-cises. Case 14-2004. A 66-year-old man with progressive neurologic deficit. N Engl. J. Med. 2004, 350:1882-1893.
32. Koralnik I.J., Wuthrich C., Dang X., Rottnek M., Gurtman A., Simpson D., Morgello S. JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy. Ann. Neurol. 2005, 57:576-580.
33. Koralnik I.J. Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy. J. Neurovirol. 2002, 8 (suppl. 2:59-65.
34. Li T.C., Takeda N., Kato K., Nilsson J., Xing L., Haag L., Cheng R.H., Miyamura T. Characterization of self-assembled virus-like particles of human polyomavirus BK generated by recombinant baculoviruses. Virology 2003, 311:115-124.
35. Major E.O., Amemiya K., Tornatore C.S., Houff S.A., Berger J.R. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin. Microbiol. Rev. 1992, 5:49-73.
36. Marzocchetti A., Cingolani A., Giambenedetto S.D., Ammassari A., Giancola M.L., Cauda R., Antinori A., Luca A.D. Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome-. J. Neurovirol. 2005, 11:219-224.
37. Munoz-Marmol A.M., Mola G., Fernandez-Vasalo A., Vela E., Mate J.L., Ariza A. JC virus early protein detection by immunohistochemistry in progressive multifocal leukoencephalopathy: a comparative study with in situ hybridization and pol. J. Neuropathol. Exp. Neurol. 2004, 63:1124-1130.
38. Pavesi A. Utility of JC polyomavirus in tracing the pattern of human migrations dating to prehistoric times. J. Gen. Virol. 2005, 86:1315-1326.
39. Pietropaolo V., Videtta M., Fioriti D., Mischitelli M., Arancio A., Orsi N., Degener A.M. Rearrangement patterns of JC virus noncoding control region from different biological samples. J. Neurovirol. 2003, 9:603-611.
40. Polo C., Perez J.L., Mielnichuck A., Fedele C.G., Niubo J., Tenorio A. Prevalence and patterns of polyomavirus urinary excretion in immunocompetent adults and children. Clin. Microbiol. Infect. 2004, 10:640-644.
41. Sabath B.F., Major E.O. Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoen-cephalopathy. J. Infect. Dis. 2002, 186(suppl. 2):S180-S186.
42. Safak M., Barrucco R., Darbinyan A., Okada Y., Nagashima K., Khalili K. Interaction of JC virus agno protein with T antigen modulates transcription and replication of the viral genome in glial cells. J. Virol. 2001, 75:1476-1486.
43. Safak M., Khalili K. An overview: human polyomavirus JC virus and its associated disorders. J. Neurovirol. 2003, 9(suppl. 1):3-9.
44. Santagata S., Kinney H.C. Mechanism of JCV entry into oligodendrocytes. Science 2005, 309:381-382.
45. Seth P., Diaz F., Major E.O. Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy. J. Neurovirol. 2003, 9:236-246.
46. Sindic C.J., Trebst C., Van Antwerpen M.P., Frye S., Enzensberger W., Hunsmann G., Luke W., Weber T. Detection of CSF-specific oligoclonal antibodies to recombinant JC virus VP1 in patients with progressive multifocal leukoencephalopathy. J. Neuroim-munol. 1997, 76(1-2):100-104.
47. Stolt A., Sasnauskas K., Koskela P., Lehtinen M., Dillner J. Seroepidemiology of the human polyomaviruses. J. Gen. Virol. 2003, 84:1499-1504.
48. Sweet T.M., Valle L.D., Khalili K. Molecular biology and immunoregulation of human neurotropic JC virus in CNS. J. Cell. Physiol. 2002, 191:249-256.
49. Tarek A.Y., Major E.O., Ryschkewitsch C., Fahle G., Fischer S., Hou J., Curfman B., Miszkiel K., Mueller-Lenke N., Sanchez E., Barkhof F., Radue E.-W., Jäger H.R., Clifford D.B. Eval-uation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl. J. Med. 2006, 354:924-933.
50. Vendrely A., Bienvenu B., Gasnault J., Thiebault J.B., Salmon D., Gray F. Fulminant inflammatory leukoencephalopathy associ-ated with HAART-induced immune restoration in AIDS-related progres-sive multifocal leukoencephalopathy. Acta Neuropathol. 2005, 109:449-455.
51. von Einsiedel R.W., Samorei I.W., Pawlita M., Zwissler B., Deubel M., Vinters H.V. New JC virus infection patterns by in situ polymerase chain reaction in brains of acquired immunodeficiency syndrome patients with progressive multifocal leuk. J. Neurovirol. 2004, 10:1-11.
52. Wang H.Y. Pathologic quiz case: a 54-year-old deceased man with diffuse subcortical lesions of the central nervous system. Progres-sive multifocal leukoencephalopathy. Arch. Pathol. Lab. Med. 2004, 128:e70-e72.
53. Wang M., Tzeng T.Y., Fung C.Y., Ou W.C., Tsai R.T., Lin C.K., Tsay G.J., Chang D. Human anti-JC virus serum reacts with native but not denatured JC virus major capsid protein VP1. J. Virol. Methods 1999, 78:171-176.
54. Weber F., Goldmann C., Kramer M., Kaup F.J., Pickhardt M., Young P., Petry H., Weber T., Luke W. Cellular and humoral immune response in progressive multifocal leukoen-cephalopathy. Ann. Neurol. 2001, 49:636-642.
55. Weber T., Trebst C., Frye S., Cinque P., Vago L., Sindic C.J., Schulz-Schaeffer W.J., Kretzschmar H.A., Enzensberger W., Hunsmann G., Luke W. Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J. Infect. Dis. 1997, 176(1):250-254.
56. Wyen C., Hoffmann C., Schmeisser N., Wohrmann A., Qurishi N., Rockstroh J., Esser S., Rieke A., Ross B., Lorenzen T., Schmitz K., Stenzel W., Salzberger B., Fatkenheuer G. Progressive multifocal leukoencephalopathy in patients on highly active antiretro-viral therapy: survival and risk factors of death. J. Acquired Immune Defic. Syndrome JAIDS 2004, 37:1263-1268.